Abstract
Noonan syndrome (NS) is a relatively common but genetically heterogeneous autosomal dominant malformation syndrome. The incidence of Noonan syndrome is estimated to be 1 in 1,000–1 in 2,500 live births.
This is a preview of subscription content, log in via an institution to check access.
References
Abuelo, D. N., & Meryash, D. L. (1988). Neurofibromatosis with fully expressed Noonan syndrome. American Journal of Medical Genetics, 29, 937–941.
Achiron, R., Heggesh, J., Grisaru, D., et al. (2000). Noonan syndrome: A cryptic condition in early gestation. American Journal of Medical Genetics, 92, 159–165.
Allanson, J. E. (1987). Noonan syndrome. Journal of Medical Genetics, 24, 9–13.
Allanson, J. E. (2001). Noonan syndrome. In S. B. Cassidy & J. E. Allanson (Eds.), Management of genetic syndromes (pp. 253–268). New York: Wiley-Liss.
Allanson, J. E., & Robert, A. E. (2011). Noonan syndrome. GeneReviews. Updated 4 Aug 2011. Available at: http://www.ncbi.nlm.nih.gov/books/NBK1124/
Allanson, J. E., Hall, J. G., Hughes, H. E., et al. (1985). Noonan syndrome: The changing phenotype. American Journal of Medical Genetics, 21, 507–514.
Artoni, A., Selicorni, A., Passamonti, S. M., et al. (2014). Hemostatic abnormalities in Noonan syndrome. Pediatrics, 133, e1299–e1304.
Binder, G. (2009). Response to growth hormone in short children with Noonan syndrome: Correlation to genotype. Hormone Research, 72(Suppl 2), 52–56.
Brems, H., Chmara, M., Sahbatou, M., et al. (2007). Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype. Nature Genetics, 39, 1120–1126.
Burch, M., Sharland, M., Shinebourne, E., et al. (1993). Cardiologic abnormalities in Noonan syndrome: Phenotypic diagnosis and echocardiographic assessment of 118 patients. Journal of the American College of Cardiology, 22, 1189–1192.
Collins, E., & Turner, G. (1973). The Noonan syndrome-a review of the clinical and genetic features of 27 cases. Journal of Pediatrics, 83, 941–950.
Jorge, A. A. L., Malaquias, A. C., Arnhold, I. J. P., et al. (2009). Noonan syndrome and related disorders: A review of clinical features and mutations in genes of the RAS/MAPK pathway. Hormone Research, 71, 185–193.
Kirk, J. M., Betts, P. R., Butler, G. E., et al. (2001). Short stature in Noonan syndrome: Response to growth hormone therapy. Archives of Disease in Childhood, 84, 440–443.
Kosaki, K., Suzuki, T., Muroya, K., et al. (2002). PTPN11 (protein-tyrosine phosphatase, nonreceptor-type 11) mutations in seven Japanese patients with Noonan syndrome. Journal of Clinical Endocrinology and Metabolism, 87, 3529–3533.
Lepri, F. R., Scavelli, R., Digilio, M. C., et al. (2014). Diagnosis of Noonan syndrome and related disorders using target next generation sequencing. BMC Medical Genetics, 15, 14–24.
Maheshwari, M., Belmont, J., Fernbach, S., et al. (2002). PTPN11 mutations in Noonan syndrome type I: Detection of recurrent mutations in exons 3 and 13. Human Mutation, 20, 298–304.
Mendez, H. M., & Opitz, J. M. (1985). Noonan syndrome: A review. American Journal of Medical Genetics, 21, 493–506.
Musante, L., Kehl, H. G., Majewski, F., et al. (2003). Spectrum of mutations in PTPN11 and genotype-phenotype correlation in 96 patients with Noonan syndrome and five patients with cardio-facio-cutaneous syndrome. European Journal of Human Genetics, 11, 201–206.
Noonan, J. A. (1994). Noonan syndrome. An update and review for the primary pediatrician. Clinical Pediatrics (Philadelphia), 33, 548–555.
Noonan, J. A., Raaijmakers, R., & Hall, B. (2003). Adult height in Noonan syndrome. American Journal of Medical Genetics, 123A, 68–71.
Ogata, T., Sato, S., Hasegawa, Y., et al. (2003). Lymphstasis in a boy with Noonan syndrome: Implication for the development of skeletal features. Endocrine Journal, 50, 319–324.
Ranke, M. B., Heidemann, P., Knupfer, C., et al. (1988). Noonan syndrome: Growth and clinical manifestations in 144 cases. European Journal of Pediatrics, 148, 220–227.
Sharland, M., Morgan, M., Smith, G., et al. (1993). Genetic counselling in Noonan syndrome. American Journal of Medical Genetics, 45, 437–440.
Tartaglia, M., Mehler, E. L., Goldberg, R., et al. (2001). Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nature Genetics, 29, 465–468.
Tartaglia, M., Kalidas, K., Shaw, A., et al. (2002). PTPN11 mutations in Noonan syndrome: Molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. American Journal of Human Genetics, 70, 1555–1563.
Tartaglia, M., Zampino, G., & Gelb, B. D. (2010). Noonan syndrome: Clinical aspects and molecular pathogenesis. Molecular Syndromology, 1, 2–26.
Witt, D. R., Keena, B. A., Hall, J. G., et al. (1986). Growth curves for height in Noonan syndrome. Clinical Genetics, 30, 150–153.
Witt, D. R., Hoyme, H. E., Zonana, J., et al. (1987). Lymphedema in Noonan syndrome: Clues to pathogenesis and prenatal diagnosis and review of the literature. American Journal of Medical Genetics, 27, 841–856.
Witt, D. R., McGillivray, B. C., Allanson, J. E., et al. (1988). Bleeding diathesis in Noonan syndrome: A common association. American Journal of Medical Genetics, 31, 305–317.
Zenker, M., Buheitel, G., Rauch, R., et al. (2004). Genotype-phenotype correlations in Noonan syndrome. Journal of Pediatrics, 144, 368–374.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this entry
Cite this entry
Chen, H. (2015). Noonan Syndrome. In: Atlas of Genetic Diagnosis and Counseling. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6430-3_180-2
Download citation
DOI: https://doi.org/10.1007/978-1-4614-6430-3_180-2
Received:
Accepted:
Published:
Publisher Name: Springer, New York, NY
Online ISBN: 978-1-4614-6430-3
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences